Roche receives clearance from the U.S. Food and Drug Administration for the new Accu-Chek® Nano SmartView blood glucose monitoring system

Innovative, small, no code device will be available to people with diabetes in the U.S. in first half of 2012


 

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the

U.S. Food and Drug Administration (FDA) for its Accu-Chek® Nano SmartView blood glucose

monitoring system. The new Accu-Chek Nano meter, which is smaller than a standard credit card, employs a large brilliant backlit display and does not require any manual coding or code key for enhanced ease of use. It also offers improved functions such as customizable test reminders, preand postmeal markers and average glucose calculation. The Accu-Chek Nano meter uses Accu-Chek® SmartView test strips and will be available to customers in the first half of 2012.

 

“We are very excited to bring this latest blood glucose monitoring technology to the United States,”said Luc Vierstraete, Global Head of Roche Diabetes Care. “The Accu-Chek Nano meter is the newest advancement in Roche’s more than 35-year commitment to bring state-of-the-art innovations to people with diabetes and their caregivers, and continues our promise to enabling optimal diabetes management. This new system will help us to further leverage and enhance our position in this important market.”

According to the 2011 National Diabetes Fact Sheet published by the Centers for Diseases Control and Prevention, more than 25 million people in the US live with diabetes. However, seven million are currently undiagnosed and 1.9 million new cases of diabetes were diagnosed in people aged 20 years and older in 2010. It is also estimated that 79 million people live with pre-diabetes in the US.

“The Accu-Chek Nano blood glucose meter will appeal to those who prefer a small, discreet meter with maximum performance and is Roche Diabetes Care’s latest innovation aimed at enabling diabetes success for our customers and their health care team,” said Marc Gibeley, Head of Roche Diabetes Care North America. “It is easy-to-use and will help people with diabetes regularly check their blood glucose levels before making informed therapy and lifestyle adjustments. We look forward to its launch later this year.”

 

Roche Diabetes Care Roche Diagnostics GmbH

Sandhofer Straße 116

D – 68305 Mannheim

Global Communications Phone +49 621 759 9561

Fax +49 621 759789561

http://www.accu- chek.com

About the Accu-Chek Nano SmartView system

The Accu-Chek Nano SmartView blood glucose monitoring system offers a small, sleek and discreet design with easy-to-use operating buttons on top of the meter. It is the first single-strip no code meter in the Accu-Chek product family. This means it does not require any coding previously needed to calibrate the meter to the respective test strips and will use the maltose-independent Accu-Chek SmartView test strips. The Accu-Chek Nano SmartView system is part of the same product line as the Accu-Chek Aviva Nano and Accu-Chek Performa Nano systems that have already been launched successfully in many markets in the EMEA, Latin-American and APAC region.

 

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80’000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

 

About Roche Diabetes Care

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 35 years, the Accu- Chek brand has been dedicated to enable people with diabetes to live life as normal and active as possible as well as to empower healthcare professionals manage their patients’ condition in an optimal way. Today, the Accu-Chek portfolio offers people with diabetes and healthcare professionals innovative products and impactful solutions for convenient, efficient and effective diabetes management. It encompasses blood glucose meters, insulin delivery systems, lancing devices, data management systems and education programs – contributing to an improved medical outcome. For more information: www.accu-chek.com.

 

For more information please contact

Ute Volkmann

Roche Diabetes Care

Todd Siesky

Roche Diabetes Care

Roche Diagnostics Roche Diagnostics

Phone: +49 621 759 9561 Phone: +1 317 521 3966

E-Mail: ute.volkmann@roche.com E-Mail: todd.siesky@roche.com

or visit

www.accu-chek.com

All trademarks used or mentioned in this release are protected by law.

 

Kitty Castellini Wins Roche Diabetes Care’s Diabetes Heroes’ Torchbearer Challenge Roche to make $10,000 donation in Castellini’s name to South Jersey JDRF Chapter

Indianapolis, Dec. 2, 2011

INDIANAPOLIS—Roche Diabetes Care, makers of ACCU-CHEK products and services, is pleased to announce that Diabetes Living Today® Founder, President and CEO Kitty Castellini is the winner of Roche’s inaugural Diabetes Heroes’ Torchbearer Challenge.

Roche launched the online Diabetes Heroes program earlier this year to highlight and recognize historic and present-day individuals who have made important contributions to help others live full lives with diabetes. The site contains three groups: Trailblazers, Torchbearers and Everyday Heroes.

Trailblazers are scientists and researchers who have made important historic discoveries about how diabetes is diagnosed and treated. Torchbearers are present-day researchers, advocates and online community leaders who continue to blaze new trails in helping people with diabetes to live healthy, active lives. To increase the visibility of this very important group of modern-day heroes, Roche produced online video profiles of each Torchbearer and encouraged people to visit the site and “like” their favorite by Nov. 14, 2011, World Diabetes Day. Castellini received the most likes and as a result Roche will donate $10,000 in her name to the South Jersey JDRF Chapter.

“A diabetes hero is an ordinary person who finds the courage and strength to persevere and endure in spite of the overwhelming obstacles of diabetes,” said Castellini.

The Diabetes Heroes site remains active and will continue to promote the incredible work being done by Kitty and her colleagues to assist people living with diabetes. Visitors to the Diabetes Heroes website may also add their own Everyday Hero by visiting the site and adding their own hero to the growing list.

 

For more information about Diabetes Living Today®, please visit http://diabeteslivingtoday.com. To learn more about the Diabetes Heroes website, please visit http://www.accu-chek.com/microsite/heroes/index.html.

###

About Roche Diabetes Care

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients’ condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management—from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems. For more information, please visit accu-chek.com.

 

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80,000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

 

About Kitty Castellini

Kitty Castellini, Founder, President and CEO of Diabetes Living Today®, has more than 47 years of experience with diabetes. Castellini is recognized as a national thought leader about diabetes by pharmaceutical companies, research institutes and those living with the disease. She is an active advocate for cure-focused research and fundraising. In 2007, the U.S. Congress acknowledged Castellini’s impressive work in helping others who suffer from diabetes through her writing, fundraising and interviews. The State of New Jersey Senate honored her for her exemplary service, steadfast commitment and praiseworthy history of inspired leadership on behalf of her fellow citizens.

 

All trademarks used or mentioned in this release are protected by law.

 

For further information, please contact:

Todd Siesky
Public Relations Manager 

Roche Diabetes Care

Indianapolis, IN

(317) 521-3966 O 

(317) 361-7637 C

todd.siesky@roche.com

 

Do the Big Blue Test and Change The World of a Person with Diabetes

Annual grassroots diabetes awareness campaign provides life-saving supplies to more than 8,000 people in need

BERKELEY, CA: Nov. 1, 2011 – People with diabetes will help change the lives for others with diabetes in need as they do something in unison – exercise. Every time someone participates in the Big Blue Test and shares the experience on BigBlueTest.org, a donation of life-saving supplies will be made on their behalf to someone with diabetes in need.

The Big Blue Test, a diabetes awareness program started by the nonprofit Diabetes Hands Foundation, takes place every November leading up to World Diabetes Day on Nov. 14. The campaign reinforces the importance of exercise in managing diabetes. People with diabetes are encouraged to do the Big Blue Test any day between November 1 and November 14 at midnight Pacific Time, by testing their blood sugar, getting active, testing again, and sharing the results online at bigbluetest.org.

The website aggregates all of the data collected live. In the last two years, just 14 minutes of exercise decreased participants’ blood sugar level between 15 and 20 percent.

In 2010, more than 2,000 people did the Big Blue Test. Over 120,000 people watched the Big Blue Test video. Roche Diabetes Care, makers of ACCU-CHEK® diabetes products and services, funded the production of the video and helped it go viral by donating 75 cents for each of the first 100,000 views, resulting in total donation of $75,000. The donation provided insulin and supplies to more than 2,000 people with diabetes in developing countries.

This year, in connection with the number of people that do the Big Blue Test, another donation from Roche Diabetes Care will benefit more than 8,000 people with diabetes in need. Five nonprofit organizations focused on helping underserved areas with a high incidence of diabetes in the United States will each receive $10,000, while $25,000 will go to support the work in Latin America by the International Diabetes Federation’s Life for a Child Programme.

“Exercise to help you – and help someone who really needs it get life-saving diabetes supplies,” said Manny Hernandez, President of the Diabetes Hands Foundation. “And join us in spreading the word so we can help 7,999 more!”

One of the recipients of the Big Blue Test grants will be Moundville Medical Clinic in Alabama. The clinic provides health services to underserved populations in rural Hale County, Alabama. In Hale County, the prevalence of diabetes runs high, while residents also face illiteracy, significant financial hardship, lack of transportation, and destruction left by 2011’s tornadoes.

“The Big Blue Test grant will enable us to provide free lab tests and individualized clinical pharmacy diabetes education and nutritional counseling to underserved people, including those impacted by the tornadoes,” said Heather Whitley, PharmD, BCPS, CDE, and director of the clinic’s diabetes program.

Visit BigBlueTest.org before midnight Pacific Time, November 14, 2011 to do the Big Blue Test, share the experience and help us touch the lives of 8,000 people with diabetes in need.

For high resolution photos of the participants in the video, visit:

http://www.tudiabetes.org/profiles/blogs/the-faces-of-the-2011-big-blue-test-video

 

About the Big Blue Test

The Big Blue Test started in 2009 as a creative way to encourage people with diabetes to stay active. It has grown into a global, viral campaign to raise awareness about the benefits of exercise for people with diabetes and help support diabetes charities in the process. It is a program organized by the Diabetes Hands Foundation, in collaboration with DiabetesDaily.com, DiabetesStories.com and the Psychology and Educational Sciences Department of the Internet Interdisciplinary Institute (IN3) at Universitat Oberta de Catalunya.

The 5 nonprofits that will benefit from $50,000 in Big Blue Test grants in the United States in 2011 are: LIFT For Teens/Walk and Play For Wellness in San Rafael, CA; Moundville Medical Clinic, near Tuscaloosa, Alabama, c/o Auburn University Harrison School of Pharmacy; Pecos Valley Medical Center, Inc. Pecos NM; St. Anthony Medical Clinic, St. Anthony Foundation in San Francisco, CA and University of Colorado Denver.

 

About World Diabetes Day

World Diabetes Day is celebrated on 14 November, a date chosen to mark the birthday of Sir Frederick Banting, one of the pioneers in diabetes research. It was introduced in 1991 by the International Diabetes Federation (IDF) and the World Health Organization (WHO) in response to the alarming rise in diabetes around the world. In 2007, the United Nations marked the Day for the first time with the passage of the United Nations World Diabetes Day Resolution in December 2006, which made the existing World Diabetes Day an official United Nations World Health Day. World Diabetes Day is represented by the blue circle logo—the global symbol of diabetes.

About Roche Diabetes Care

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients’ condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management—from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems. For more information, please visit accu-chek.com.

 

About Auburn University

Auburn University has provided instruction, research and outreach to benefit the state and nation for more than 155 years, and is among a distinctive group of universities designated as Land, Sea, and Space Grant institutions. Auburn makes a nearly $5 billion economic contribution to the state each year, has more than 250,000 graduates and provides 140 degree programs to more than 25,000 graduate and undergraduate students.